Table 1

Information collected in the pilot project

DomainInitial screeningAssessment for high-risk subjects1-month follow-up
Patient interviews
 Health behaviours
  Smoking
  Alcohol use/misuse
  Physical activity
  Dietary
 Medical history
  Hypertension
  Diabetes
  MI
  PCI
  CABG
  Stroke
  Angina
  Heart failure
  Valvular heart disease
  Arrhythmia
  Hypercholesterolaemia
  Dyslipidaemia
  Chronic renal disease
  Peripheral vascular disease
  Cancer (except skin cancer)
 Family history of disease
  Hypertension
  CHD
  Ischaemic stroke
  Haemorrhage stroke
  Diabetes
  Cancer
  Hypercholesterolaemia
 Identification of special case
  Family history of longevity, premature death, and chronic disease
 Medication history
  Antihypertension
  Lipid-lowering
  Antidiabetic
  Antiplatelet
  Traditional Chinese medicine
 Menstruation
  Menstrual period
  Menopause
  Pregnancy
 Quality of life (EQ-5D-3L)
 Survival status
  Date and cause of death
 Hospitalisations
  Date of admission
  Length of hospitalisation
  Diagnosis of discharge
Physical measurements
 Blood pressure
 Height
 Weight
 BMI
Lipid blood test
 TC
 TG
 LDL-C
 HDL-C
Imaging examinations
 ECG
 Echocardiogram
 Carotid artery ultrasound
Biosamples
 Blood
 Urine
Laboratory analysis
 Biochemistry test
  Blood lipid
  Glucose
  ALT
  AST
  Creatinine
  Uric acid
  HbA1c
 Urine routine test
  Glucose
  Ketone
  Occult blood
  Protein
  Nitrite
  Bilirubin
  Gravity
  pH
  Urobilinogen
  Erythrocyte
  Leucocyte
  • ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CABG, coronary artery bypass grafting; CHD, coronary heart disease; ECG, 12-lead ECG; HbA1c, glycated haemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; PCI, percutaneous coronary intervention; TC, total cholesterol; TG, triglyceride.